NCT04327622|Completed
Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population
PEDAL
Loading search results
PEDAL
Sponsor study identifier
observational
5,084
1 country
1
Study Start
March 3, 2020
Actual (reported)Primary Completion
June 30, 2020
Actual (reported)Study Completion
June 30, 2020
Actual (reported)The study aims to assess foot complications among patients with diabetes in Canada, using patient data collected during diabetes foot assessments performed by the LMC Chiropody Team between February 27, 2018 and April 17, 2019.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 3, 2020
Actual (reported)March 27, 2020
Actual (reported)March 31, 2020
Actual (reported)June 30, 2020
Actual (reported)June 30, 2020
Actual (reported)Prevalence of diabetes foot complications: foot ulcer
Proportion of patients diagnosed with a foot ulcer
24-hours
Prevalence of diabetes foot complications: onychocryptosis
Proportion of patients with onychocryptosis
24-hours
Prevalence of diabetes foot complications: onychomycosis
Proportion of patients with onychomycosis
24-hours
Patients with diabetes at LMC Diabetes \& Endocrinology, who were provided with an initial diabetes foot assessment supported by funding from Bausch Canada. The diabetes foot assessments were performed by the LMC Chiropody Team at seven of the Ontario LMC clinics between February 27, 2018 and April 17, 2019.
LMC Healthcare
Toronto, Canada
Ronnie Aronson, MD
LMC Healthcare
5,084 participants (actual enrollment reported by the registry).
First Submitted
March 27, 2020
First Posted
March 31, 2020
Study Start
March 3, 2020
Actual (reported)The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians
Prevalence of diabetes foot complications: onychauxis
Proportion of patients with onychauxis
24-hours
Prevalence of diabetes foot complications: hyperkeratosis
Proportion of patients with hyperkeratosis
24-hours
Prevalence of diabetes foot complications: foot deformities
Proportion of patients with foot deformities
24-hours
Prevalence of diabetes foot complications: neuropathy risk
Risk for neuropathy will be measured using the modified Toronto Clinical Neuropathy Score (mTCNS)
24-hours
Diabetes foot assessment risk group
24-hours
Association between foot risk variables and the presence of a foot ulcer
24-hours
Contact the study team to confirm eligibility.
Primary Completion
June 30, 2020
Actual (reported)Study Completion
June 30, 2020
Actual (reported)Last Updated
February 25, 2021
Record last verified: 2020-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: